ArticleSignal transduction and targeted therapy2024

Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein.

Qi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.